1. Combined utility of CD177, P53, CD105 and c-kit immunohistochemical stains improves the detection of myelodysplastic syndrome
   Tariq N. Aladily et al, 2021, Annals of Diagnostic Pathology CrossRef
2. Myeloid nuclear differentiation antigen: an aid in differentiating lymphoplasmacytic lymphoma and splenic marginal zone lymphoma in bone marrow biopsies at presentation
   Simona Righi et al, 2022, Human Pathology CrossRef
3. Bone Marrow Changes Following Therapy and Immunosuppression
   Alexandar Tzankov, 2020, Diagnostic Bone Marrow Haematopathology CrossRef
4. High‐level MYC expression associates with poor survival in patients with acute myeloid leukemia and collaborates with overexpressed p53 in leukemic transformation in patients with myelodysplastic syndrome
   Linlin Gao et al, 2021, International Journal of Laboratory Hematology CrossRef
5. Histopathology in the diagnosis of high-risk myelodysplastic syndromes
   Hidekazu Kayano, 2018, Journal of Clinical and Experimental Hematopathology CrossRef
6. TP53 in Myelodysplastic Syndromes: Recent Biological and Clinical Findings
   Cosimo Cumbo et al, 2020, International Journal of Molecular Sciences CrossRef